| abstract |
The disclosure relates to materials and methods for the treatment of hepatitis C. In particular, peptides are disclosed based on amino acid sequences within the E2 polypeptide of the hepatitis C virus, and to vaccine compositions comprising these peptides. Additionally, the disclosure relates to methods of treating or preventing hepatitis C infection by administration of a vaccine composition comprising the peptides. |